Latest and Current IPO GMP Updates: June 2025

By
On:
Follow Us

Latest and Current IPO GMP Updates: June 2025: Are you wondering which Initial Public Offerings (IPOs) are creating buzz in June 2025? The latest and current IPO GMP updates are your gateway to understanding market sentiment before shares hit the stock exchanges. The Grey Market Premium (GMP) reflects how much investors are willing to pay above the IPO issue price in the unofficial grey market, offering a sneak peek into potential listing gains—or losses. With market volatility and tariff uncertainties impacting the Indian IPO scene, staying updated on GMP trends is crucial for making informed investment decisions.

In this article, we’ll dive into the latest IPO GMP updates for June 2025, explore trending IPOs, analyze key factors influencing GMP, and provide actionable insights to help you navigate the IPO landscape. Whether you’re a retail investor or a seasoned trader, this guide is packed with expert analysis and real-world examples to empower your investment journey.

Understanding IPO Grey Market Premium (GMP)

What Is IPO GMP?

The IPO Grey Market Premium (GMP) is the difference between the IPO issue price and the price at which shares are traded in the grey market before official listing. The grey market is an unregulated, over-the-counter market where shares are bought and sold before they debut on stock exchanges like BSE or NSE. For instance, if an IPO is priced at ₹100 and its GMP is ₹20, the estimated listing price could be around ₹120.

Why Is GMP Important?

  • Gauges Investor Sentiment: A high GMP signals strong demand and bullish sentiment, while a low or negative GMP suggests caution.
  • Predicts Listing Performance: Though not foolproof, GMP often indicates potential listing gains or losses.
  • Guides Investment Decisions: Investors use GMP to decide whether to apply for an IPO or trade in the grey market.

Note: GMP is speculative and not always accurate. Always consider company fundamentals and market conditions before investing.

Latest IPO GMP Updates for June 2025

The Indian IPO market in June 2025 is buzzing with activity, despite recent hiccups due to tariff uncertainties. Below, we highlight the latest and current IPO GMP updates for some of the most talked-about IPOs, based on recent market data.

Current IPOs and Their GMP

IPO NameIssue Price (₹)GMP (₹)GMP (%)Estimated Listing Price (₹)Subscription DatesExchange
HDB Financial Services8808810%968June 24–26BSE, NSE
Kalpataru Ltd387–4145012%464June 24–26BSE, NSE
Globe Civil Projects67–7157%76June 24–26BSE, NSE
Ellenbarrie Industrial Gases380–4004010%440June 24–26BSE, NSE
Sambhv Steel Tubes821012%92June 25–27BSE, NSE
Influx Healthtech91–964547%141June 18–20NSE SME
Mayasheel Ventures90–961011%106June 20–24NSE SME
Ace Alpha Tech100–1051514%120June 26–30BSE SME

Source: ipowatch.in, investorgain.com

Key Observations

  • High GMP Performers: Influx Healthtech’s 47% GMP reflects strong investor enthusiasm, driven by its niche in healthcare technology.
  • Mainboard Stability: HDB Financial Services and Kalpataru Ltd show moderate GMPs (10–12%), indicating steady demand amid market volatility.
  • SME Volatility: SME IPOs like Mayasheel Ventures and Ace Alpha Tech have lower GMPs, signaling cautious optimism.
  • Low GMP Concerns: Arisinfra Solutions’ 0% GMP suggests weak demand, potentially leading to a flat or discounted listing.

Factors Influencing IPO GMP in June 2025

1. Market Sentiment

The Indian stock market in June 2025 is navigating tariff-related uncertainties, impacting investor confidence. A bullish market typically boosts GMP, while bearish conditions can suppress it. For example, recent posts on X highlight subdued GMPs for IPOs like Sambhv Steel Tubes (8–14%), reflecting cautious sentiment.

2. Company Fundamentals

Strong financials and growth prospects drive higher GMPs. HDB Financial Services, backed by HDFC Bank, enjoys a 10% GMP due to its robust loan portfolio and brand credibility. Conversely, weaker fundamentals, as seen in Arisinfra Solutions, result in negligible GMP.

3. Subscription Rates

High subscription rates often correlate with elevated GMPs. Influx Healthtech’s 16.77x subscription on June 20, 2025, fueled its 47% GMP. Low subscriptions, like those for Oswal Pumps (31% on Day 1), can dampen GMP.

4. Sector Trends

Sectors like healthcare (Influx Healthtech) and financial services (HDB Financial) are in favor, boosting GMPs. Industrial sectors, such as Sambhv Steel Tubes, face softer demand due to global trade concerns.

Case Studies: IPO GMP Success and Challenges

Success: Influx Healthtech IPO

  • Details: Priced at ₹91–96, Influx Healthtech’s IPO (June 18–20, 2025) saw a 47% GMP, translating to an estimated listing price of ₹141.
  • Why It Worked: Strong subscription (16.77x), growing demand for healthtech, and positive grey market sentiment.
  • Takeaway: High GMPs in niche sectors can signal significant listing gains, but investors should verify fundamentals.

Challenge: Arisinfra Solutions IPO

  • Details: Priced at ₹222, Arisinfra Solutions (June 18–20, 2025) recorded a 0% GMP, indicating no premium in the grey market.
  • Why It Struggled: Weak subscription rates and broader market uncertainty dampened investor interest.
  • Takeaway: A low GMP may warn of a flat or discounted listing, urging caution.

How to Use IPO GMP Wisely

1. Don’t Rely Solely on GMP

GMP is speculative and can fluctuate rapidly. For example, Oswal Pumps’ GMP dropped from 10% to 7% before listing, leading to a lackluster debut. Always research the company’s financials, business model, and industry trends.

2. Monitor Subscription Trends

High subscription rates often validate GMP trends. Check live subscription data on platforms like Moneycontrol or Chittorgarh.

3. Evaluate Market Conditions

Tariff uncertainties in June 2025 are impacting GMPs. Stay updated via trusted sources like NDTV Profit or IPO Central.

4. Consult Financial Advisors

GMP is a tool, not a guarantee. Seek advice from SEBI-registered advisors to align IPO investments with your financial goals.

Internal Links:

Outbound Links:

Follow Fundmetry.com for more financial updates.

FAQ Section

1. What is IPO GMP, and how is it calculated?

Answer: The IPO Grey Market Premium (GMP) is the premium at which IPO shares are traded in the grey market before their official listing. It’s calculated as the difference between the grey market trading price and the IPO issue price. For example, if an IPO is priced at ₹100 and trades at ₹120 in the grey market, the GMP is ₹20. GMP reflects investor sentiment but isn’t a guaranteed predictor of listing price. Factors like subscription rates, market conditions, and company fundamentals influence GMP. In June 2025, IPOs like Influx Healthtech (47% GMP) show strong demand, while Arisinfra Solutions (0% GMP) indicate caution. Always cross-check GMP with financial reports and consult advisors.

2. How reliable is IPO GMP for predicting listing gains?

Answer: IPO GMP offers insight into market sentiment but isn’t fully reliable for predicting listing gains. A high GMP, like Influx Healthtech’s 47% in June 2025, suggests strong demand, but actual listing prices depend on market conditions, subscription rates, and institutional investor interest. For instance, some high-GMP IPOs list below expectations, while low-GMP IPOs can outperform. In June 2025, tariff uncertainties are suppressing GMPs for IPOs like Sambhv Steel Tubes (8–14%). To improve accuracy, monitor subscription data, read analyst reports, and assess company fundamentals. GMP is a tool, not a crystal ball.

3. Which IPOs in June 2025 have the highest GMP?

Answer: In June 2025, Influx Healthtech leads with a 47% GMP, reflecting strong investor interest in healthtech. Its IPO, priced at ₹91–96, is estimated to list at ₹141. Other notable IPOs include HDB Financial Services (10% GMP, estimated listing at ₹968) and Kalpataru Ltd (12% GMP, estimated listing at ₹464). SME IPOs like Ace Alpha Tech (14% GMP) and Mayasheel Ventures (11% GMP) also show promise. However, GMPs can fluctuate, as seen with Sambhv Steel Tubes (8–14%). Check platforms like ipowatch.in for real-time updates and verify with company fundamentals before investing.

4. Should I invest in an IPO with a low or negative GMP?

Answer: A low or negative GMP, like Arisinfra Solutions’ 0% in June 2025, signals weak demand and potential for a flat or discounted listing. However, it doesn’t automatically mean the IPO is a bad investment. Low GMPs can result from temporary market sentiment or oversupply in the grey market. For long-term investors, focus on the company’s financials, growth prospects, and sector trends. For example, a fundamentally strong company with a low GMP might offer value if market conditions improve post-listing. Short-term traders should avoid low-GMP IPOs due to limited listing gains. Always consult financial advisors.

5. How can I track the latest IPO GMP updates in June 2025?

Answer: To track the latest and current IPO GMP updates in June 2025, use trusted platforms like ipowatch.in, investorgain.com, and chittorgarh.com, which provide real-time GMP data, subscription rates, and IPO calendars. Financial news sites like Moneycontrol and NDTV Profit offer expert analysis. Social media platforms like X can provide sentiment but verify claims, as posts may be speculative. For example, X posts on June 23, 2025, reported Sambhv Steel Tubes’ GMP at 8–10%. Set alerts on brokerage apps like Zerodha or 5paisa for IPO updates. Cross-reference data with company prospectuses for informed decisions.

6. What are the risks of trading in the IPO grey market?

Answer: Trading in the IPO grey market carries significant risks due to its unregulated nature. Transactions are cash-based, lack formal contracts, and rely on trust, increasing fraud risks. GMPs are volatile; for instance, Oswal Pumps’ GMP fell from 10% to 7% before listing in June 2025. If the actual listing price is below the GMP, buyers may incur losses. Low subscription rates or negative market sentiment can also lead to discounted listings. Investors should avoid grey market trading unless experienced and focus on regulated IPO applications via brokers like 5paisa or Religare Broking. Consult SEBI-registered advisors for safer strategies.

Conclusion: Stay Ahead with IPO GMP Updates

The latest and current IPO GMP updates for June 2025 reveal a dynamic market with opportunities and risks. High-GMP IPOs like Influx Healthtech (47%) and HDB Financial Services (10%) signal strong demand, while low-GMP IPOs like Arisinfra Solutions (0%) urge caution. By understanding GMP, monitoring subscription trends, and evaluating company fundamentals, you can make informed investment decisions.

Stay proactive by tracking GMP on platforms like ipowatch.in and consulting financial advisors. Share your thoughts in the comments below, subscribe to our newsletter for weekly IPO updates, or explore our IPO Investment Guide for deeper insights. What’s your take on June 2025 IPOs? Let’s discuss!

Internal Links:

Outbound Links:

Leave a Comment